Publication: Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Loading...
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
American Association for Cancer Research Inc.